Effect of a glucagon receptor antibody (REMD-477) in type 1 diabetes: A randomized controlled trial

Glucagon therapeutics: Dawn of a new era for diabetes care

(2016) Jaime A. Davidson et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D exchange clinic registry

(2015) Mark A. Clements et al.   PEDIATRIC DIABETES

Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway

(2015) May-Yun Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover

(2012) Roger H. Unger et al.   JOURNAL OF CLINICAL INVESTIGATION

Hypoglycemia in Type 1 Diabetes

(2010) R. J. McCrimmon et al.   DIABETES

On the role of glucose-dependent insulintropic polypeptide in postprandial metabolism in humans

(2009) Meena Asmar et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Homozygous P86S Mutation of the Human Glucagon Receptor Is Associated With Hyperglucagonemia, α Cell Hyperplasia, and Islet Cell Tumor

(2009) Cuiqi Zhou et al.   PANCREAS